BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 16794390)

  • 1. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
    Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
    Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the localization and surgical management of duodenal gastrinomas.
    Lawton GP; Modlin IM
    Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pancreatic endocrine tumors].
    Târcoveanu E; Moldovanu R; Georgescu S; Niculescu D; Lupaşcu C; Dimofte G
    Chirurgia (Bucur); 2006; 101(2):175-81. PubMed ID: 16752684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of insulinomas in multiple endocrine neoplasia type 1.
    Giudici F; Nesi G; Brandi ML; Tonelli F
    Pancreas; 2012 May; 41(4):547-53. PubMed ID: 22228047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
    Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
    World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parathyroid glands involvement in multiple endocrine neoplasia].
    Târcoveanu E; Niculescu D; Cotea E; Moldovanu R; Vasilescu A; Crumpei F; Zbranca E; Zugun F; Rusu V; Ferariu D
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):482-96. PubMed ID: 21495355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1.
    Lopez CL; Falconi M; Waldmann J; Boninsegna L; Fendrich V; Goretzki PK; Langer P; Kann PH; Partelli S; Bartsch DK
    Ann Surg; 2013 Feb; 257(2):308-14. PubMed ID: 22580937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
    Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
    Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
    Imamura M; Komoto I; Ota S; Hiratsuka T; Kosugi S; Doi R; Awane M; Inoue N
    World J Gastroenterol; 2011 Mar; 17(10):1343-53. PubMed ID: 21455335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine tumors of the pancreas.
    Meko JB; Norton JA
    Curr Opin Gen Surg; 1994; ():186-94. PubMed ID: 7583963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2001 Oct; 234(4):495-505; discussion 505-6. PubMed ID: 11573043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.
    Davì MV; Boninsegna L; Dalle Carbonare L; Toaiari M; Capelli P; Scarpa A; Francia G; Falconi M
    Neuroendocrinology; 2011; 94(1):58-65. PubMed ID: 21464564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Zollinger-Ellison syndrome].
    Fendrich V; Bartsch DK; Langer P; Zielke A; Rothmund M
    Chirurg; 2005 Mar; 76(3):217-26. PubMed ID: 15688179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
    Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
    J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery to cure the Zollinger-Ellison syndrome.
    Norton JA; Fraker DL; Alexander HR; Venzon DJ; Doppman JL; Serrano J; Goebel SU; Peghini PL; Roy PK; Gibril F; Jensen RT
    N Engl J Med; 1999 Aug; 341(9):635-44. PubMed ID: 10460814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.
    Imamura M; Komoto I; Ota S
    World J Surg; 2006 Jan; 30(1):1-11. PubMed ID: 16369713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.